Extract from the Register of European Patents

EP About this file: EP1259260

EP1259260 - COMBINATION THERAPY FOR THE TREATMENT OF INFLAMMATORY AND RESPIRATORY DISEASES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.09.2004
Database last updated on 21.03.2026
Most recent event   Tooltip28.08.2009Change - representativepublished on 30.09.2009  [2009/40]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[N/P]
Former [2002/48]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, Indiana 46285 / US
Inventor(s)01 / MACIAS, William, Louis
9129 Log Run South Drive
Indianapolis, IN 46234 / US
 [2002/48]
Representative(s)Pritchard, Judith, et al
Eli Lilly and Company Limited
Lilly Research Centre
Erl Wood Manor
Windlesham
Surrey GU20 6PH / GB
[N/P]
Former [2009/40]Pritchard, Judith, et al
Eli Lilly and Company Limited Lilly Research Centre Erl Wood Manor Windlesham
Surrey GU20 6PH / GB
Former [2002/48]Pritchard, Judith, et al
Eli Lilly and Company Limited Lilly Research Centre Erl Wood Manor Sunninghill Road
Windlesham, Surrey GU20 6PH / GB
Application number, filing date00990230.522.12.2000
[2002/48]
WO2000US34262
Priority number, dateUS20000174723P06.01.2000         Original published format: US 174723 P
[2002/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0149323
Date:12.07.2001
Language:EN
[2001/28]
Type: A1 Application with search report 
No.:EP1259260
Date:27.11.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 12.07.2001 takes the place of the publication of the European patent application.
[2002/48]
Search report(s)International search report - published on:EP12.07.2001
ClassificationIPC:A61K45/06, A61P11/00, A61P29/00
[2002/48]
CPC:
A61K45/06 (EP); A61K31/404 (KR); A61P1/00 (EP);
A61P1/18 (EP); A61P11/00 (EP); A61P11/06 (EP);
A61P19/02 (EP); A61P19/06 (EP); A61P21/00 (EP);
A61P29/00 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P7/00 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/48]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:KOMBINATIONSTHERAPIE ZUR BEHANDLUNG ENTZÜNDLICHER UND RESPIRATORISCHER ERKRANKUNGEN[2002/48]
English:COMBINATION THERAPY FOR THE TREATMENT OF INFLAMMATORY AND RESPIRATORY DISEASES[2002/48]
French:THERAPIE COMBINEE DESTINEE AU TRAITEMENT DE MALADIES INFLAMMATOIRES ET RESPIRATOIRES[2002/48]
Entry into regional phase06.08.2002National basic fee paid 
06.08.2002Designation fee(s) paid 
06.08.2002Examination fee paid 
Examination procedure01.06.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
01.07.2002Amendment by applicant (claims and/or description)
06.08.2002Examination requested  [2002/48]
21.01.2003Despatch of a communication from the examining division (Time limit: M04)
02.06.2003Reply to a communication from the examining division
08.10.2003Despatch of a communication from the examining division (Time limit: M06)
20.04.2004Application deemed to be withdrawn, date of legal effect  [2004/44]
25.05.2004Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2004/44]
Fees paidRenewal fee
02.01.2003Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.12.200304   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]   FURUNO T ET AL: "The role of neutrophil elastase in human pulmonary artery endothelial cell injury.", INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, (1997 MAR) 112 (3) 262-9., XP000879176 [Y] 1-16 *see in particular abstract, Figure 8 and discussion *

DOI:   http://dx.doi.org/10.1159/000237464
 [X]   KOKOTOS G. ET AL: "Synthesis of medicinally useful lipidic.alpha.-amino acids, 2-amino alcohols and diamines.", AMINO ACIDS, (1996) 11/3-4 (329-343)., XP000994915 [X] 1,10,16 *see in particular the abstract, and chapter "enzyme inhibitors" bridging pages 333 and 334 *

DOI:   http://dx.doi.org/10.1007/BF00807940
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.